How much revenue does Laurus Labs make?

Laurus Labs reported 55.54 billion INR in revenue for fiscal year 2025, up 10.2% from 50.41 billion INR in fiscal year 2024. In Q3 2026 revenue was 17.78 billion INR.

Where does Laurus Labs make most of its revenue?

outside India: 68% of revenue by region in fiscal year 2025, followed by India (32%).

What companies are similar to Laurus Labs?

Listed companies of a similar size in the same industry (drug manufacturing contractors) include Divi's Laboratories Limited (DIVISLAB.NS), Gland Pharma Limited (GLAND.NS), Neuland Laboratories Limited (NEULANDLAB.NS), Piramal Pharma Limited (PPLPHARMA.NS).

Laurus Labs Limited (LAURUSLABS.NS) Stock

About Laurus Labs Limited

Laurus Labs Limited, together with its subsidiaries, manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally. The company offers Generics APIs and solid oral drug products for intermediates for anti-retroviral (ARV), anti-diabetic, cardiovascular, anti-asthma, ophthalmology, oncology, and gastroenterology. It also develops and manufactures animal-...

At a glance

Laurus Labs reported revenue of 55.54 billion INR for fiscal year 2025, up 10.2% from fiscal year 2024, and net income of 3.58 billion INR. In Q3 2026 (the quarter ended December 31, 2025) revenue was 17.78 billion INR, up 25.7% from a year before. outside India was its largest region in fiscal year 2025, with 68% of revenue.

Figures from company filings; latest fiscal year ended March 31, 2025.

No profile data available.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.